Skip to content
  • News and Events
  • Magazine
  • Reach us
  • Members Area
  • Restricted area
  • Italiano
  • News and Events
  • Magazine
  • Reach us
  • Members Area
  • Restricted area
  • Italiano
  • Foundation
  • Foundation
        • Foundation

        • About us
        • Mission and Values
        • Policies
        • History
        • Executive Board
        • Transparency
  • Research
  • Research
        • Research

        • Our Commitment
        • Brain and Nervous System
        • Muscle Pathophysiology and Regeneration
        • Advanced Oncology
        • Regenerative Medicine and Innovative Technologies
        • Technological Platforms
  • People
  • People
        • People

        • Staff
        • Founding members
        • Research groups
        • Work with us
  • Support us
    • One-off donation
  • Support us
        • Support us

        • Support Our Research
        • One-off donation
        • Become a Recurring Donor
        • Memorial Donation
        • Bequests
        • 5×1000
        • Companies
Donate now

Archives: Scoperte

Padi4-dependent NETosis enables diet-induced gut hyperpermeability, translating dysbiosis into systemic inflammation and dysmetabolism.

Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World Study.

Long-term effects of adding an SGLT-2 inhibitor to insulin therapy in patients with type 1 diabetes. An observational study and systematic review of real-world evidence.

Oncostatin M is dispensable for the regulation of hematopoietic stem/progenitor cell traffic by neutrophils.

Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease.

Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world study.

Modelling POLG mutations in mice unravels a critical role of POLγΒ in regulating phenotypic severity.

Opantimirs: A class of antagonizing microRNAs that upregulate Opa1 and improve mitochondrial and disuse myopathies.

Metastatic breast cancer cells are selectively dependent on the mitochondrial cristae-shaping protein OPA1.

A guide to characterizing the dynamic mitochondria-endoplasmic reticulum contact sites.

← Previous
Next →
  • Reach us
  • Work with us
  • News and Events
  • Magazine
  • Tax Benefits
  • Reach us
  • Work with us
  • News and Events
  • Magazine
  • Tax Benefits
  • About us
  • Research
  • Technological Platforms
  • People
  • About us
  • Research
  • Technological Platforms
  • People

Every donation supports the challenges faced by our researchers. With your help, you contribute to finding solutions to improve people's quality of life.

Donate now
[mc4wp_form id="7234"]

Via Orus, 2
35129 Padova
+39 049 7923211

info@fondbiomed.it
C.F. 92102180285
P.IVA 03709640282
IBAN: IT96J0306912117100000013003 

  • Reach us
  • Work with us
  • News and Events
  • Magazine
  • Tax Benefits
  • Reach us
  • Work with us
  • News and Events
  • Magazine
  • Tax Benefits
  • About us
  • Research
  • Technological Platforms
  • People
  • About us
  • Research
  • Technological Platforms
  • People
  • Privacy and Cookie Policy
  • Cookie preferences
  • Cookie preferences
  • Whistleblowing
  • Transparency
  • Whistleblowing
  • Credits
  • Credits
  • Privacy and Cookie Policy
  • Cookie preferences
  • Cookie preferences
  • Whistleblowing
  • Transparency
  • Whistleblowing
  • Credits
  • Credits
  • Privacy and Cookie Policy
  • Cookie preferences
  • Cookie preferences
  • Whistleblowing
  • Transparency
  • Whistleblowing
  • Credits
  • Credits
  • Privacy and Cookie Policy
  • Cookie preferences
  • Cookie preferences
  • Whistleblowing
  • Transparency
  • Whistleblowing
  • Credits
  • Credits
  • Foundation
  • Foundation
    • About us
    • Mission and Values
    • Policies
    • History
    • Executive Board
    • Transparency
  • Research
  • Research
    • Our Commitment
    • Brain and Nervous System
    • Muscle Pathophysiology and Regeneration
    • Advanced Oncology
    • Regenerative Medicine and Innovative Technologies
    • Technological Platforms
  • People
  • People
    • Staff
    • Founding members
    • Research groups
    • Work with us
  • Support us
    • One-off donation
  • Support us
    • Support Our Research
    • One-off donation
    • Become a Recurring Donor
    • Memorial Donation
    • Bequests
    • 5×1000
    • Companies
  • News and Events
  • Magazine
  • Reach us
  • Members Area
  • Restricted area
  • Italiano
  • Search the site

Support Our Research

Donate now
  • Foundation
  • Foundation
    • About us
    • Mission and Values
    • Policies
    • History
    • Executive Board
    • Transparency
  • Research
  • Research
    • Our Commitment
    • Brain and Nervous System
    • Muscle Pathophysiology and Regeneration
    • Advanced Oncology
    • Regenerative Medicine and Innovative Technologies
    • Technological Platforms
  • People
  • People
    • Staff
    • Founding members
    • Research groups
    • Work with us
  • Support us
    • One-off donation
  • Support us
    • Support Our Research
    • One-off donation
    • Become a Recurring Donor
    • Memorial Donation
    • Bequests
    • 5×1000
    • Companies
  • News and Events
  • Magazine
  • Reach us
  • Members Area
  • Restricted area
  • Italiano
  • Search the site

Support Our Research

Donate now